Publicaciones en las que colabora con Rosa María Tordera Baviera (23)

2023

  1. SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 529-550

2020

  1. THE SAMP8 MOUSE AS A MODEL OF ACCELERATED SENESCENCE

    Encyclopedia of Cell Biology: New Research (9 Volume Set) (Nova Science Publishers, Inc.), pp. 1465-1492

2018

  1. The SAMP8 mouse as a model of accelerated senescence

    New Research on Cell Aging and Death (Nova Science Publishers, Inc.), pp. 1-42

2017

  1. Stress animal models for the study of neuropsychiatric and neurodegenerative disorders

    Horizons in Neuroscience Research (Nova Science Publishers, Inc.), pp. 51-101

2016

  1. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

    Hippocampus, Vol. 26, Núm. 10, pp. 1303-1312

2015

  1. Venlafaxine reverses decreased proliferation in the subventricular zone in a rat model of early life stress

    Behavioural Brain Research, Vol. 292, pp. 79-82

2014

  1. Glutamate and GABA: partners in crime in stress-induced cognitive dysfunction

    Cognitive dysfunctions: biological basis, management of symptoms and long-term neurological implications (NOVA Publishers), pp. 63-86

  2. Revealing the cerebral regions and networks mediating vulnerability to depression: Oxidative metabolism mapping of rat brain

    Behavioural Brain Research, Vol. 267, pp. 83-94

  3. Serotonergic therapies for cognitive symptoms in alzheimer's disease: Rationale and current status

    Drugs, Vol. 74, Núm. 7, pp. 729-736

2013

  1. Regulation of serotonin (5-HT) function by a VGLUT1 dependent glutamate pathway

    Neuropharmacology, Vol. 70, pp. 190-199

  2. Stress contributes to the development of central insulin resistance during aging: Implications for Alzheimer's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 12, pp. 2332-2339

2012

  1. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus

    Neuropharmacology, Vol. 62, Núm. 5-6, pp. 1944-1953

  2. Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers

    British Journal of Pharmacology, Vol. 165, Núm. 4, pp. 897-907

2011

  1. Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex

    European Neuropsychopharmacology, Vol. 21, Núm. 1, pp. 23-32

2010

  1. Interactions between age, stress and insulin on cognition: Implications for alzheimer's disease

    Neuropsychopharmacology, Vol. 35, Núm. 8, pp. 1664-1673

  2. Regulation of markers of synaptic function in mouse models of depression: Chronic mild stress and decreased expression of VGLUT1

    Journal of Neurochemistry, Vol. 114, Núm. 5, pp. 1302-1314

  3. Sustained stress-induced changes in mice as a model for chronic depression

    Psychopharmacology, Vol. 210, Núm. 3, pp. 393-406

2009

  1. Effects of neonatal stress on markers of synaptic plasticity in the hippocampus: Implications for spatial memory

    Hippocampus, Vol. 19, Núm. 12, pp. 1222-1231

  2. Increased Vulnerability to Depressive-Like Behavior of Mice with Decreased Expression of VGLUT1

    Biological Psychiatry, Vol. 66, Núm. 3, pp. 275-282

  3. Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: Involvement of the HPA axis

    Psychoneuroendocrinology, Vol. 34, Núm. 10, pp. 1495-1505